LOMAIRA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lomaira, and what generic alternatives are available?
Lomaira is a drug marketed by Avanthi Inc and is included in one NDA.
The generic ingredient in LOMAIRA is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lomaira
A generic version of LOMAIRA was approved as phentermine hydrochloride by ELITE LABS INC on May 30th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOMAIRA?
- What are the global sales for LOMAIRA?
- What is Average Wholesale Price for LOMAIRA?
Summary for LOMAIRA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 44 |
| Clinical Trials: | 4 |
| Patent Applications: | 909 |
| Drug Prices: | Drug price information for LOMAIRA |
| DailyMed Link: | LOMAIRA at DailyMed |
Recent Clinical Trials for LOMAIRA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| HealthPartners Institute | Phase 4 |
| The University of Texas Health Science Center, Houston | Phase 4 |
| Kaiser Permanente | Phase 4 |
Pharmacology for LOMAIRA
| Drug Class | Sympathomimetic Amine Anorectic |
| Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
US Patents and Regulatory Information for LOMAIRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avanthi Inc | LOMAIRA | phentermine hydrochloride | TABLET;ORAL | 203495-001 | Sep 12, 2016 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
